Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Bioorg Med Chem Lett ; 19(8): 2333-7, 2009 Apr 15.
Article in English | MEDLINE | ID: mdl-19286381

ABSTRACT

2,7-Diamino-thiazolo[4,5-d]pyrimidine analogues were synthesized as novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Representative compounds showed potent and selective EGFR inhibitory activities and inhibited in vitro cellular proliferation in EGFR-overexpressing human tumor cells. The synthesis and preliminary biological, physical, and pharmacokinetic evaluation of these thiazolopyrimidine compounds are reported.


Subject(s)
Antineoplastic Agents/chemical synthesis , ErbB Receptors/antagonists & inhibitors , Protein Kinase Inhibitors/analogs & derivatives , Protein Kinase Inhibitors/chemical synthesis , Pyrimidines/chemical synthesis , Antineoplastic Agents/pharmacology , Cell Line, Tumor , Cell Proliferation/drug effects , Drug Screening Assays, Antitumor/methods , Humans , Protein Kinase Inhibitors/pharmacology , Pyrimidines/pharmacology
3.
J Med Chem ; 51(14): 4068-71, 2008 Jul 24.
Article in English | MEDLINE | ID: mdl-18578516

ABSTRACT

11beta-Hydroxysteroid dehydrogenase type 1 (11beta-HSD1) is the enzyme that converts cortisone to cortisol. Evidence suggests that selective inhibition of 11beta-HSD1 could treat diabetes and metabolic syndrome. Presented herein are the synthesis, structure-activity relationship, and in vivo evaluation of piperazine sulfonamides as 11beta-HSD1 inhibitors. Through modification of our initial lead 5a, we have identified potent and selective 11beta-HSD1 inhibitors such as 13q and 13u with good pharmacokinetic properties.


Subject(s)
11-beta-Hydroxysteroid Dehydrogenase Type 1/antagonists & inhibitors , Disease Models, Animal , Enzyme Inhibitors/pharmacology , Hyperinsulinism/drug therapy , Piperazines/pharmacology , Sulfonamides/pharmacology , Administration, Oral , Animals , Biological Availability , Cortisone/pharmacology , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/pharmacokinetics , Enzyme Inhibitors/therapeutic use , Hyperinsulinism/chemically induced , Hyperinsulinism/enzymology , Piperazines/administration & dosage , Piperazines/pharmacokinetics , Piperazines/therapeutic use , Rats , Sulfonamides/administration & dosage , Sulfonamides/pharmacokinetics , Sulfonamides/therapeutic use
4.
J Med Chem ; 50(19): 4681-98, 2007 Sep 20.
Article in English | MEDLINE | ID: mdl-17705360

ABSTRACT

Protein tyrosine phosphatase 1B (PTP1B) is a negative regulator of the insulin and leptin receptor pathways and thus an attractive therapeutic target for diabetes and obesity. Starting with a high micromolar lead compound, structure-based optimization of novel PTP1B inhibitors by extension of the molecule from the enzyme active site into the second phosphotyrosine binding site is described. Medicinal chemistry, guided by X-ray complex structure and molecular modeling, has yielded low nanomolar PTP1B inhibitors in an efficient manner. Compounds from this chemical series were found to be actively transported into hepatocytes. This active uptake into target tissues could be one of the possible avenues to overcome the poor membrane permeability of PTP1B inhibitors.


Subject(s)
Models, Molecular , Phosphotyrosine/metabolism , Protein Tyrosine Phosphatases/antagonists & inhibitors , Thiophenes/chemical synthesis , Animals , Binding Sites , Caco-2 Cells , Catalytic Domain , Cell Membrane Permeability , Crystallography, X-Ray , Half-Life , Hepatocytes , Humans , In Vitro Techniques , Male , Mice , Mice, Inbred C57BL , Microsomes, Liver/metabolism , Molecular Structure , Phosphotyrosine/chemistry , Protein Tyrosine Phosphatase, Non-Receptor Type 1 , Protein Tyrosine Phosphatases/chemistry , Rats , Rats, Sprague-Dawley , Solubility , Structure-Activity Relationship , Thiophenes/pharmacokinetics , Thiophenes/pharmacology , Tissue Distribution
5.
Bioorg Med Chem Lett ; 17(10): 2913-20, 2007 May 15.
Article in English | MEDLINE | ID: mdl-17336064

ABSTRACT

The following account describes our systematic effort to replace one of the carboxylate groups of our diacid thiophene PTP1B inhibitors. Active hits were validated using enzymatic assays before pursuing efforts to improve the potency. Only when the C2 carboxylic acid was replaced with another ionizable functional group was reversible and competitive inhibition retained. Use of a tetrazole ring or 1,2,5-thiadiazolidine-3-one-1,1-dioxide as a carboxylate mimetic led to the discovery of two unique starting series that showed improved permeability (PAMPA) and potency of the order of 300nM. The SAR from these efforts underscores some of the major challenges in developing small molecule inhibitors for PTP1B.


Subject(s)
Protein Tyrosine Phosphatases/antagonists & inhibitors , Thiophenes/pharmacology , Acids/chemistry , Drug Design , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/classification , Humans , Molecular Structure , Protein Tyrosine Phosphatase, Non-Receptor Type 1 , Protein Tyrosine Phosphatases/metabolism , Structure-Activity Relationship , Thiophenes/chemistry
6.
Org Lett ; 8(11): 2425-8, 2006 May 25.
Article in English | MEDLINE | ID: mdl-16706542

ABSTRACT

[reaction: see text] An efficient one-step amination of cyclic amides and ureas has been developed. Treatment of cyclic amides and cyclic ureas with BOP in the presence of DBU in various solvents led to the formation of cyclic amidines and cyclic guanidines in good to excellent yields. Concise syntheses of biologically intriguing kinetin and potent kinase inhibitor olomoucin were thus achieved in just one and two steps, respectively.


Subject(s)
Amides/chemistry , Amidines/chemical synthesis , Guanidines/chemical synthesis , Kinetin/chemical synthesis , Urea/chemistry , Amination , Catalysis , Molecular Structure
7.
Org Lett ; 7(26): 5877-80, 2005 Dec 22.
Article in English | MEDLINE | ID: mdl-16354089

ABSTRACT

[reaction: see text] A highly facile and efficient one-step synthesis of N6-adenosine and N6-2'-deoxyadenosine derivatives has been developed. Treatment of inosine or 2'-deoxyinosine, without protection of sugar hydroxyl groups, with alkyl or arylamines, in the presence of BOP and DIPEA in DMF, led to the formation of N6-adenosine and N6-2'-deoxyadenosine derivatives in good to excellent yields. Carcinogenic polyaromatic hydrocarbon (PAH) N6-2'-deoxyadenosine adduct 10 and a rare DNA constituent 11 were thus synthesized directly from 2'-deoxyinosine both in 98% yield.


Subject(s)
Adenosine , Combinatorial Chemistry Techniques , Deoxyadenosines/chemical synthesis , Adenosine/analogs & derivatives , Adenosine/chemical synthesis , Adenosine/chemistry , Molecular Structure
8.
J Org Chem ; 67(5): 1705-7, 2002 Mar 08.
Article in English | MEDLINE | ID: mdl-11871910

ABSTRACT

Stereochemically well-defined homoallylic thioethers 3 are synthesized via Lewis acid promoted condensation reaction between chiral organosilane reagents 2 and in situ generated thionium ions. The stereochemical course of the reaction is consistent with earlier reports concerning crotylsilations of oxonium ions.


Subject(s)
Ethers/chemical synthesis , Quaternary Ammonium Compounds/chemistry , Silanes/chemistry , Acetals/chemistry , Alkanes/chemistry , Butanols/chemistry , Catalysis , Chemistry, Organic/methods , Ethers/chemistry , Ketones/chemistry , Magnetic Resonance Spectroscopy , Molecular Structure , Stereoisomerism , Sulfur/chemistry , Tin Compounds/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...